Raheja, P., Knott, A., Lowe, G., Tsiamita, O., Lorch, U., Goricar, M., Nagilla, P., O'Meara, T., Amin, J., Mathy, S., Ostergaard, H., Sorensen, B., Rea, C. (2025). Velora pioneer, Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of HMB-002 for prophylaxis in von Willebrand disease: A trial in progress. Blood. https://doi.org/10.1182/blood-2025-8230